Azitra Inc (AZTR) - Total Liabilities
Based on the latest financial reports, Azitra Inc (AZTR) has total liabilities worth $1.22 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see AZTR current and non-current assets.
Azitra Inc - Total Liabilities Trend (2021–2025)
This chart illustrates how Azitra Inc's total liabilities have evolved over time, based on quarterly financial data. See AZTR net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Azitra Inc Competitors by Total Liabilities
The table below lists competitors of Azitra Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Expion360 Inc
NASDAQ:XPON
|
USA | $1.32 Million |
|
WestKam Gold Corp
V:WKG
|
Canada | CA$880.07K |
|
Halo Technologies Holdings Ltd
AU:HAL
|
Australia | AU$408.41 Million |
|
Beam Communications Holdings Ltd
AU:BCC
|
Australia | AU$3.61 Million |
|
AEST.MED.INT.HLD.SP.ADR/3
F:3FMA
|
Germany | €554.12 Million |
|
Ostrom Climate Solutions Inc
V:COO
|
Canada | CA$13.69 Million |
|
British Smaller Companies Vct Plc
LSE:BSV
|
UK | GBX297.00K |
Liability Composition Analysis (2021–2025)
This chart breaks down Azitra Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check AZTR asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Azitra Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Azitra Inc (2021–2025)
The table below shows the annual total liabilities of Azitra Inc from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.22 Billion | +73621.95% |
| 2024-12-31 | $1.66 Million | -24.60% |
| 2023-12-31 | $2.20 Million | -94.93% |
| 2022-12-31 | $43.43 Million | +20.74% |
| 2021-12-31 | $35.97 Million | -- |
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer pat… Read more